Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine for Dysfunction in Bipolar Disorder
NCT00741598Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2008
- Primary completion
- May 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of galantamine in bipolar disorder (BD), sponsored by Icahn School of Medicine at Mount Sinai. Started Sep 2008; status: completed.
02
Drugs
galantamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00741598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741598.